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Typhonium flagelliforme from the family Araceae is locally known as rodent 
tuber. It is being used traditionally in Malaysia to treat cancer. The major aim of this 
study was to investigate the effect of Typhonium flagelliforme crude extract on 
hepatocarcinogenesis in rats induced by diethylnitrosamine (DEN) and 2-
acetyl amino fluorene (AAF). Besides the in vivo study, the plant's nutrient and non-
nutrient composition, and its antioxidant activity were also determined. Typhonium 
flagelliforme has carbohydrate (0.5% in leaves-stalks and 27.5% in tubers-roots) as its 
main constituent. It has high content of vitamin C (106.5 mg/IOO g in leaves-stalks and 
11.6 mg/IOO g in tubers-roots) and potassium (1276.8 mg/IOO g in leaves-stalks and 
534 mg/IOO g in tubers-roots). Alkaloid (0.4 mg/IOO g in leaves-stalks and 0.9 mg/IOO 
g in tubers-roots) and catechin (1.5% in leaves-stalks and 0.7% in tubers-roots) were 
found in this plant. The phytochemicals of Typhonium flagelliforme showed a greater 
antioxidant activity than vitamin E. The effect of Typhonium flagelliforme crude 
extract (0.1 ml/rat) on rat hepatocarcinogenesis was assessed by five different tumour 
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markers [gamma glutamyl transpeptidase (GGT), uridyl diphosphoglucuronyl 
transferase (UDPGT), glutathione S-transferase (GST), alkaline phosphatase (ALP) and 
glutathione (GSH)] and histological examinations. Glycyrrhizin [0.005% (w/v)] was 
used as a comparison to Typhonium flagelliforme crude extract. Administration of 
diethylnirosamine and 2-acetylaminofluorene (DEN/AAF) significantly increased the 
activities of plasma and liver microsomal GGT (p<0.05), liver microsomal UDPGT 
(p<0.05), liver GST (p<0.05), liver ALP (p<O.OO l )  and the concentration of liver GSH 
(p<0.0 1 )  compared to control. Supplementation of Typhonium flagelliforme crude 
extract to normal rats did not give any effect towards the tumour markers. The crude 
extract administered to the DEN/AAF treated rats significantly dec�eased the activities 
of plasma and liver microsomal GGT (p<0.05), liver microsomal UDPGT (p<0.05), 
liver GST (p<0.05), liver ALP (p<O.OOl )  and the concentration of GSH (p<O.O l )  when 
compared to the DEN/AAF treated rats. Glycyrrhizin, which was given to the 
DEN/AAF treated rats reduced all the tumour markers except ALP (p>O.OO l ). Light 
microscopic examination showed that DEN/AAF caused hepatocytic dysplasia. 
Transmission electron micrographs showed organelles damage caused by DEN/AAF. 
No morphological and histological changes were seen on the cells and the organelles 
when the DEN/AAF treated rats were supplemented with the crude extract. These 
results suggested that Typhonium flagelliforme contained constituents that help in 
preventing liver cancer and its crude extract administered at this supplemented dose (0. 1 
ml) to the DEN/AAF treated rats reduced the severity of hepatocarcinogenesis better 
than glycyrrhizin [0.005% (w/v)]. 
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Typhonium flagelliforme dari famili Araceae dikenali sebagai keladi tikus di 
negara ini. Ia digunakan secara tradisional di Malaysia untuk merawat kanser. Objektif 
utama kajian ini adalah mengkaji kesan ekstrak kasar Typhonium flagelliforme terhadap 
hepatokarsinogenesis tikus yang diaruh dengan dietilnitrosamin (DEN) dan 2-
asetilaminofluoren (AAF). Selain daripada kajian in vivo, komposisi nutrien dan 
antinutrien serta aktiviti antioksidan tumbuhan ini juga telah dikaji. Karbohidrat (0.5% 
dalam daun-batang dan 27.5% dalam ubi-akar) merupakan konstituen utama Typhonium 
flagelliforme. Ia mengandungi vitamin C ( 1 06.5 mg/ I OO g dalam daun-batang dan 1 1 .6 
mg/I OO g dalam ubi-akar) dan kalium ( 1276.8 mg/ lOO g dalam daun-batang dan 534 
mg/lOO g dalam ubi-akar) yang tinggi. Alkaloid (0.4 mg/lOO g dalam daun-batang dan 
0.9 mg/ I OO g dalam ubi-akar) dan katekin ( 1 .5% dalam daun-batang dan 0.7% dalam 
ubi-akar) terdapat dalam tumbuhan ini. Sebatian fitokimia Typhonium flagelliforme 
memberi kesan antioksidan yang lebih baik daripada vitamin E. Kesan ekstrak kasar 
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Typhonium flagelliforme pada hepatokarsinogenesis tikus c:lt\t:B8ldSif �i lima 
penanda kanser [garna glutarnil transpeptidase (GGT), uridil difosfoglukuronil 
transferase (UDPGT), glutation S-transferase (GST), alkalin fosfatase (ALP), glutation 
(GSH)] dan pemeriksaan histologi. Glycyrrhizin [0.005% (w/v)] digunakan sebagai 
pembanding kepada ekstrak kasar Typhonium flagelliforme. Pemberian dietilnitrosarnin 
dan 2-asetilarninofluoren (DEN/ AAF) meningkatkan dengan ketara aktiviti-aktiviti 
GGT plasma dan mikrosom hepar (p<O.05), UDPGT mikrosom hepar (p<O.05), GST 
hepar (p<0.05), ALP hepar (p<O.OO l )  dan kepekatan GSH hepar (p<O.O l )  berbanding 
dengan kawalan. Suplementasi ekstrak kasar Typhonium flagelliforme kepada tikus 
normal tidak memberi sebarang kesan terhadap penanda-penanda kanser. Ekstrak kasar 
yang diberikan kepada tikus-tikus diaruh DEN/AAF mengurangkan dengan ketara 
aktiviti-aktiviti GGT plasma dan mikrosom (p<O.05), UDPGT mikrosom (p<0.05), GST 
hepar (p<O.05), ALP hepar (p<O.OO l )  dan kepekatan GSH hepar (p<O.O l )  apabila 
dibandingkan dengan tikus-tikus diaruh DEN/AAF. Glycyrrhizin yang diberikan 
kepada tikus-tikus diaruh DEN/ AAF mengurangkan kesemua penanda kecuali ALP 
(p>0.00 1 ). Pemeriksaan mikroskopi cahaya menunjukkan bahawa DEN/AAF 
menyebabkan displasia. Mikrograf transmisi elektron menunjukkan kerosakkan 
organel-organel disebabkan oleh DEN/ AAF. Tiada perubahan morfologi dan histologi 
kelihatan pada sel-sel hepar dan organel-organelnya bagi tikus yang diaruh DEN/ AAF 
dan disuplementasi dengan ekstrak kasar tumbuhan ini. Hasil kajian ini mencadangkan 
bahawa Typhonium flagelliforme mengandungi komponen-komponen yang dapat 
menghalang kanser hepar dan ekstrak kasamya yang diberikan kepada tikus-tikus 
DEN/AAF pada dos ini (0. 1  ml/tikus) mengurangkan keterukan hepatokarsinogenesis 
dengan lebih baik daripada glycyrrhizin [0.005% (w/v)] . 
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Cancer is a discase. which today remains difficult to cure but is preventable by 
the administration of one or several chemical compounds. Ministry of Health Malaysia 
( 1995) has statisticall) reported that malignant neoplasm (45%) is the major cause of 
death in government hospitals, which is 2.5 times higher than the heart diseases (16%). 
Hepatocarcinogenesis or hepatocellular carcinoma or liver cancer is one of the 
most prevalent and deadly cancers worldwide (Kathryn et ai., 1997). The liver is one of 
the most frequently damaged organs in the body, and it is indeed fortunate that it has an 
enormous functional reserve. Liver is an important metabolic organ. It is involved in 
the catabolism of many endogenous substances, and has the capacity to metabolise 
foreign carcinogens. Not only can reactions therein lead to direct-acting ultimate 
carcinogens but also additional reactions lead to conjugates which are in transport 
forms. Where specific tissues or cells have the enzymatic potential to split the active 
entities from their transport conjugates, cancer may result at such sites. 
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The sequence of events leading to tumour formation and the resulting cascading 
effects of the metastases has not been completely elucidated. What had been charted are 
various steps beginning with an insult to genetic cellular material (genotoxic event; 
known also as "initiation") and then to production of abnormal DNA non-genotoxic 
event: known as "promotion"). The transformation of the altered cell may lead to the 
proliferation of cells with invasive (malignant) or non-invasive (benign) qualities. From 
a confined region of tissue, cancer spreads to other tissues (developing secondary 
tumours or metastases), and finally, to an ultimate cascading effect of the tumourous 
cells (Nagy and Attaway, 1992). 
Through animal studies, measuring tumour marker enzymes can identify the 
presence of cancer quantitatively by biochemical or immunochemical means in tissue or 
body fluids. This is further validated by histological examination for diagnosing 
neoplasia. Electron microscopy has made visible for the first time those cellular 
structures that are the morphological bases of metabolic process. 
Human are exposed to large numbers of carcinogenic chemicals and other 
carcinogenic stimuli (Le., ultraviolet light, radon, x-rays, etc.) in their daily life.  Small 
amounts of many naturally occurring mutagens and carcinogens are ingested in our 
normal diet, and it is not known whether a lifetime of eating small amounts of these 
dietary carcinogens can cause or contribute to cancer in some people. In addition to the 
carcinogens and mutagens in our diet, we also ingest large numbers of naturally 
occurring anti-mutagens and anti-carcinogens. Epidemiological studies indicate that 
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dietary factors play an important role in the development of human cancer. and attempts 
to identify these naturally occurring dietary carcinogens and anti-carcinogens should 
lead to new strategies for cancer prevention. 
If there is one aspect of medical practice that has united the physicians of the 
world throughout the millennia despite all their diverse opinions. is their reliance on our 
flora as a staple source of medicinal drugs. Virtually all early civilisations developed 
the use of plant drugs to a high degree. Traditional medicine is well known for its high 
nutritional value, as well as, its ability to cure various ailments. Treatments and 
remedies have varied greatly over the centuries; no fewer than 3000 plant species have 
been used by the laity to treat cancer (Lewis and Elvin-Lewis, 1977). Most of the early 
treatments had little or no effect on the disease, but perhaps they lessened suffering 
either physically or psychologically. Many herbal formulas were used in cancer 
treatment but none, as far as is known, was recorded as a cure. 
In treating cancer, several plants are used in Malaysia traditionally, such as 'akar 
susun kelapa' (Tabernaemontana divaricata), 'akar melur'(Jasminum sambac), 'bunga 
raya putih'(Hibiscus rosa-sinesis) and 'ubi bemban'(Marantha arundinacea). One of 
the greatest advantages of herbal medicine as a therapy is that when administered 
correctly it is completely safe (Zakaria and Mohd., 1994). 
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Typhonium flagelliforme is a green plant about one foot tall .  Its flower ends in a 
long filament resembling the tail of a mouse, hence its popular lay name rodent tuber. 
The plant grows readily in soft, damp shady areas. It has been used in traditional 
medicine for treating different types of malignancy. 
Objectives 
Even though Typhonium jlagelliforme has been used traditionally to cure cancer and 
it is gaining popularity among the scientists, its nutritional and non-nutritional 
composition has never been reported. In vivo studies on cancer using this plant were 
not done yet. Therefore, the objectives of this study were: 
1) To determine the nutrient and non-nutrient composition of Typhoniumjlagelliforme 
such as the proximate analysis, mineral, vitamins, alkaloid, tannin and catechin 
content. 
2) To evaluate the antioxidant activity of different parts of Typhoniumjlagelliforme. 
3) To determine the effect of the crude extract of Typhonium jlagelliforme III 
suppressing the process of hepatocarcinogenesis in rats by assessing the body and 
liver weight, histological examinations (light and transmission electron 
microscopy), and tumour markers activities such as gamma glutamyl transpeptidase, 
glutathione S-transferase, alkaline phosphatase, uridyl diphosphoglucuronyl 
transferase and glutathione S-transferase dependent substrate, glutathione. 
4) To compare the anticarcinogenic activity of Typhonium jlagelliforme with 





Typhonium is derived from the word Typhon, a mythological giant: the name 
was given by the ancients to some Aroid. A genus embracing about thirteen species of 
stove, tuberous, parennial herbs, inhabiting tropical Asia, Australasia, and the Pacific 
Islands represents the family Araceae. The species known to cultivation are T Brownii, 
T cuspidatum, T divaricatum, T diversifolium Huegelianum, and T trilobatum. They 
thrive in light, rich soil, and during the growing season require an abundant supply of 
water. After the leaves have died down, water must be withheld until growth 
recommences. The pots containing the tubers can be stored away in any dry, warm 
place (Nicholson, 1991). 
Plants of Typhonium flagelliforme (Lodd.) Blume were previously described as 
Typhonium divaricatum (Nicholson and Sivadasan, 1981). In Malaysia and Singapore, 
Typhonium flagelliforme (Plate 1 and 2) is locally known as "rodent tuber" (Neoh, 
1992). Characteristic of Typhonium flagelliforme are sterile flowers spreading, lower 
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ones spatulate but upper ones increasingly subulate; spathe pale greenish, extremely 
narrow and elongate and leaves usuaily narrowly hastate. 
Rare fatty acids i.e. benzenetridecanoic acid and benzenetridecanoic acid methyl 
ester, from this species were isolated (Chen el at., 1997). Preliminary tests showed that 
Typhonium flagelliforme suppress cancer cells such as leukaemia, colon carcinoma and 
melanoma. The extract, which is mixed with honey and drunk immediately. may be 
taken as single therapy or taken during the course of radiotherapy or chemotherapy. 
There are apparently no serious long-term side effects (Neoh, 1992). 
Plate 1: Typhonium flagelliforme. (--.,)) Flower Resembling the Tail of a Mouse. 
